ACTIVATION OF THE PHOSPHOLIPASE CYCLOOXYGENASE CASCADE IN THE RABBIT CORNEA BY PLATELET-ACTIVATING-FACTOR IS CHALLENGED BY PAF RECEPTOR ANTAGONISTS

被引：12

作者：

HURST, JS ^{[1
]}

BAZAN, HEP ^{[1
]}

机构：

[1] LOUISIANA STATE UNIV,MED CTR,SCH MED,CTR EYE,NEW ORLEANS,LA 70112

来源：

JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS | 1995年 / 11卷 / 03期

关键词：

D O I：

10.1089/jop.1995.11.329

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

Platelet-activating factor (PAF) is a potent lipid inflammatory mediator which is generated in the cornea after injury. Its activity is regulated by interaction with specific receptors. The binding of PAF to its receptors initiates biochemical sequences that cluminate in the release of additional lipid mediators. An arachidonoyl-dependent phospholipase A(2) is activated to release arachidonic acid from membrane phospholipids, especially phosphatidylcholine and ethanolamine. Arachidonic acid is then predominantly metabolized by the cyclooxygenase pathway to prostagiandins F-2 alpha, E(2) and D-2, whereas the lipoxygenase pathway is not influenced by PAF. The release of arachidonic acid and prostaglandins stimulated by PAF is challenged by the PAF receptor antagonists BN 50727 and BN 50730. PAF acting intracellularly may also induce the synthesis of cyclooxygenase, presumably the 'inducible' isoform PGHS2, which has been implicated in the inflammatory response. Thus, the therapeutic use of PAF receptor angatonists could be potentially beneficial in the management of ocular inflammatory disease.

引用

页码：329 / 337

页数：9

共 39 条

[1]

Braquet P., Touqui L., Shen T.Y., Vargaftig B.B., Perspectives in platelet-activating factor research, Pharmacol. Rev., 39, pp. 97-145, (1987)

[2]

Prescott S.M., Zimmerman G.A., McIntyre T.M., Platelet-activating factor, Biol. Chem., 265, pp. 17381-17384, (1990)

[3]

Snyder F., Platelet-activating factor and its analogs: Metabolic pathways and related intracellular processes, Biochim. Biophys. Acta, 1254, pp. 231-249, (1995)

[4]

Hwang S.-B., Specific receptors in platelet-activating factor receptor heterogeneity and signal transduction mechanisms, J. Lipid Mediat, 2, (1990)

[5]

Hwang S.-B., Lam M.H., Pong S.S., Ionic and GTP regulation of binding of platelet-activating factor induced activation of GTP-ase in rabbit platelet membrane, J. Biol. Chem., 261, pp. 532-537, (1986)

[6]

Honda Z., Nakamura M., Miki I., Et al., Cloning by functional expression of platelet-activating factor receptor from guinea-pig lung, Nature, 394, pp. 342-346, (1991)

[7]

Nakamura M., Honda Z., Izumi T., Et al., Molecular cloning and expression of platelet-activating factor receptor from human leukocytes, J. Biol. Chern, 266, pp. 20400-20405, (1991)

[8]

Ye R.D., Prossitz E.R., Zuo A., Cochrane C.G., Characterization of a human cDNA that encodes a functional receptor for platelet-activating factor, Biochem. Biophys Res. Commun., 180, pp. 105-111, (1991)

[9]

Marcheselli V.L., Rossowska M., Domingo M.T., Braquet P., Bazan N.G., Distinct platelet-activating factor binding sites in synaptic endings and in intracellular membranes of rat cerebral cortex, J. Biol. Chem., 265, pp. 9140-9145, (1990)

[10]

Marcheselli V.L., Bazan N.G., Platelet-activating factor is a messenger in the electroconvulsive shock-induced transcriptional activation of c-fos and zif-268 in hippocampus, J. Neurosci. Res., 37, pp. 54-61, (1994)

← 1 2 3 4 →